Eterna Therapeutics Inc. (NASDAQ: ERNA) Stock Information | RedChip

Eterna Therapeutics Inc. (NASDAQ: ERNA)


$2.08
-0.0100 ( -0.48% ) 1.1K

Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.

Market Data


Open


$2.08

Previous close


$2.09

Volume


1.1K

Market cap


$11.25M

Day range


$1.98 - $2.11

52 week range


$0.84 - $2.96

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Aug 10, 2023
8-k 8K-related 31 Aug 02, 2023
8-k 8K-related 16 Jul 18, 2023
4 Insider transactions 1 Jul 18, 2023
4 Insider transactions 1 Jul 18, 2023
4 Insider transactions 1 Jul 18, 2023
8-k 8K-related 13 Jul 13, 2023
3 Insider transactions 2 Jul 11, 2023
3 Insider transactions 2 Jul 11, 2023
8-k 8K-related 12 Jul 11, 2023

Latest News